Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Carr

Showing results (251-260 of 289) with videos related to

Pageof 29
Sort By:
The Lancet. HIV|May 11, 2024
Switch to fixed-dose doravirine (100 mg) with islatravir (0·75 mg) once daily in virologically suppressed adults with HIV-1 on bictegravir, emtricitabine, and tenofovir alafenamide: 48-week results of a phase 3, randomised, controlled, double-blind, non-inferiority trialAnthony M Mills, Giuliano Rizzardini, Moti N Ramgopal, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 19, 2022
Characteristics of Human Immunodeficiency Virus (HIV) Seroconversions in a Large Prospective Implementation Cohort Study of Oral HIV Preexposure Prophylaxis in Men Who Have Sex with Men (EPIC-NSW)Nila J Dharan, Fengyi Jin, Stefanie Vaccher, et al.
BMJ Open|November 27, 2025
Study protocol for a randomised controlled trial to determine the efficacy of lisdexamfetamine for the treatment of acute methamphetamine withdrawal in inpatient settingsLiam S Acheson, Krista J Siefried, Nicholas Lintzeris, et al.
Lancet (London, England)|February 7, 2026
Switch to fixed-dose doravirine (100 mg) and islatravir (0·25 mg) once daily in virologically suppressed adults with HIV-1 on oral antiretroviral therapy: 48-week results of a phase 3, multicentre, randomised, open-label, non-inferiority trialChloe Orkin, Rosie Mngqibisa, Juan Diego Velez, et al.
Health Technology Assessment (Winchester, England)|November 23, 2021
Unicompartmental compared with total knee replacement for patients with multimorbidities: a cohort study using propensity score stratification and inverse probability weightingAlbert Prats-Uribe, Spyros Kolovos, Klara Berencsi, et al.
European Journal of Human Genetics : EJHG|January 27, 2011
The effect of genome-wide association scan quality control on imputation outcome for common variantsLorraine Southam, Kalliope Panoutsopoulou, N William Rayner, et al.
BMC Medical Genetics|November 18, 2010
Common genetic variation in the Estrogen Receptor Beta (ESR2) gene and osteoarthritis: results of a meta-analysisHanneke J M Kerkhof, Ingrid Meulenbelt, Andrew Carr, et al.
Science Translational Medicine|November 28, 2014
Changing the mindset in life sciences toward translation: a consensusGeorg N Duda, David W Grainger, Megan L Frisk, et al.
RMD Open|September 8, 2017
Salivary gland ultrasound abnormalities in primary Sjögren's syndrome: consensual US-SG core items definition and reliabilitySandrine Jousse-Joulin, Emmanuel Nowak, Divi Cornec, et al.
American Journal of Epidemiology|February 3, 2021
A New Method for Estimating the Incidence of Infectious DiseasesHamish McManus, Denton Callander, Jason Asselin, et al.
Pageof 29

Showing results (251-260 of 289) with videos related to

Sort By:
Pageof 29
The Lancet. HIV|May 11, 2024
Switch to fixed-dose doravirine (100 mg) with islatravir (0·75 mg) once daily in virologically suppressed adults with HIV-1 on bictegravir, emtricitabine, and tenofovir alafenamide: 48-week results of a phase 3, randomised, controlled, double-blind, non-inferiority trialAnthony M Mills, Giuliano Rizzardini, Moti N Ramgopal, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 19, 2022
Characteristics of Human Immunodeficiency Virus (HIV) Seroconversions in a Large Prospective Implementation Cohort Study of Oral HIV Preexposure Prophylaxis in Men Who Have Sex with Men (EPIC-NSW)Nila J Dharan, Fengyi Jin, Stefanie Vaccher, et al.
BMJ Open|November 27, 2025
Study protocol for a randomised controlled trial to determine the efficacy of lisdexamfetamine for the treatment of acute methamphetamine withdrawal in inpatient settingsLiam S Acheson, Krista J Siefried, Nicholas Lintzeris, et al.
Lancet (London, England)|February 7, 2026
Switch to fixed-dose doravirine (100 mg) and islatravir (0·25 mg) once daily in virologically suppressed adults with HIV-1 on oral antiretroviral therapy: 48-week results of a phase 3, multicentre, randomised, open-label, non-inferiority trialChloe Orkin, Rosie Mngqibisa, Juan Diego Velez, et al.
Health Technology Assessment (Winchester, England)|November 23, 2021
Unicompartmental compared with total knee replacement for patients with multimorbidities: a cohort study using propensity score stratification and inverse probability weightingAlbert Prats-Uribe, Spyros Kolovos, Klara Berencsi, et al.
European Journal of Human Genetics : EJHG|January 27, 2011
The effect of genome-wide association scan quality control on imputation outcome for common variantsLorraine Southam, Kalliope Panoutsopoulou, N William Rayner, et al.
BMC Medical Genetics|November 18, 2010
Common genetic variation in the Estrogen Receptor Beta (ESR2) gene and osteoarthritis: results of a meta-analysisHanneke J M Kerkhof, Ingrid Meulenbelt, Andrew Carr, et al.
Science Translational Medicine|November 28, 2014
Changing the mindset in life sciences toward translation: a consensusGeorg N Duda, David W Grainger, Megan L Frisk, et al.
RMD Open|September 8, 2017
Salivary gland ultrasound abnormalities in primary Sjögren's syndrome: consensual US-SG core items definition and reliabilitySandrine Jousse-Joulin, Emmanuel Nowak, Divi Cornec, et al.
American Journal of Epidemiology|February 3, 2021
A New Method for Estimating the Incidence of Infectious DiseasesHamish McManus, Denton Callander, Jason Asselin, et al.
Pageof 29